Lidocaine Hydrochloride NDC 70954-518

NDC codes

FDA NDC Directory

Product NDC (as listed)70954-518Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70954-0518Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70954-518-10	70954051810	1 BOTTLE in 1 CARTON (70954-518-10) / 50 mL in 1 BOTTLEMarketed from Mar 23, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lidocaine Hydrochloride
Generic name (nonproprietary): lidocaine hydrochloride
Active ingredients: Lidocaine hydrochloride — 40 mg/mL
Dosage form: Solution
Route: Topical
Labeler: Novitium Pharma LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216250
Marketing start: Mar 23, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 70954-518_ffb2d794-2c88-48a2-beff-d01b6fcea51fSPL ID ffb2d794-2c88-48a2-beff-d01b6fcea51fSPL set ID ffb2d794-2c88-48a2-beff-d01b6fcea51fRxCUI 1010878UNII V13007Z41AUPC 0370954518105
Pharmacologic class: Amide Local Anesthetic; Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470954051810 followed by a unit qualifier and the quantity

Package 70954-0518-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 25, 2022.

Indications (excerpt from the label)

INDICATIONS Lidocaine hydrochloride is indicated for the production of topical anesthesia of accessible mucous membranes of the oral and nasal cavities and proximal portions of the digestive tract.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216250

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216250
Product	Strength	Form · route	Labeler	Product NDC
Lidocaine Hydrochloride	Lidocaine hydrochloride 40 mg/mL	SolutionTopical	Marlex Pharmaceuticals, Inc.	10135-736